Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

365 ARTÍCULOS , VIENDO DEL 181 AL 195

Effectiveness of a Standardized and Specific Follow-Up in Memory Centers in Patients with Alzheimer's Disease

Rouch L, Cestac P, Cool C, Helmer C, Dartigues JF, Berr C, Rouaud O, Vellas B, Andrieu S; REAL-FR Study Group and the 3C Study Group.

Curr Alzheimer Res. 2017;14(3):255-267. doi: 10.2174/1567205013666161108114850.

A Comparison of Sex Differences in Psychotropic Medication Use in Older People with Alzheimer's Disease in the US and Finland

Moga DC, Taipale H, Tolppanen AM, Tanskanen A, Tiihonen J, Hartikainen S, Wu Q, Jicha GA, Gnjidic D.

Drugs Aging. 2017 Jan;34(1):55-65. doi: 10.1007/s40266-016-0419-5.

[Organizational features influencing health worker's fulfillment in an Alzheimer center and in a nursing home]

Ghiglia S, Garrino L, Gargano A, Raspo S, Pira E, Dimonte V.

G Ital Med Lav Ergon. 2017 Jan;38(4):275-283.

Antipsychotic Use and the Risk of Hip Fracture Among Community-Dwelling Persons With Alzheimer's Disease

Koponen M, Taipale H, Lavikainen P, Tanskanen A, Tiihonen J, Tolppanen AM, Ahonen R, Hartikainen S.

J Clin Psychiatry. 2017 Mar;78(3):e257-e263. doi: 10.4088/JCP.15m10458.

Discontinuation, Efficacy, and Safety of Cholinesterase Inhibitors for Alzheimer's Disease: a Meta-Analysis and Meta-Regression of 43 Randomized Clinical Trials Enrolling 16 106 Patients

Blanco-Silvente L, Castells X, Saez M, Barceló MA, Garre-Olmo J, Vilalta-Franch J, Capellà D.

Int J Neuropsychopharmacol. 2017 Jul 1;20(7):519-528. doi: 10.1093/ijnp/pyx012.

Adherence and Tolerability of Alzheimer's Disease Medications: A Pragmatic Randomized Trial

Campbell NL, Perkins AJ, Gao S, Skaar TC, Li L, Hendrie HC, Fowler N, Callahan CM, Boustani MA.

J Am Geriatr Soc. 2017 Jul;65(7):1497-1504. doi: 10.1111/jgs.14827. Epub 2017 Mar 14.

A Black Alzheimer's Patient Wants To Be Part Of The Cure

Gray K.

Health Aff (Millwood). 2017 Jun 1;36(6):1129-1132. doi: 10.1377/hlthaff.2017.0296.

Strengthening the Case for Epilepsy Drug Development: Bridging Experiences from the Alzheimer's Disease Field-An Opinion

Twyman RE.

Neurochem Res. 2017 Jul;42(7):2099-2115. doi: 10.1007/s11064-017-2300-2. Epub 2017 Jun 7.

DPP4 Inhibitors Can Be a Drug of Choice for Type 3 Diabetes: A Mini Review

Chalichem NSS, Gonugunta C, Krishnamurthy PT, Duraiswamy B.

Am J Alzheimers Dis Other Demen. 2017 Nov;32(7):444-451. doi: 10.1177/1533317517722005. Epub 2017 Jul 27.

Vitamin B12 in Association with Antipsychotic Drugs Can Modulate the Expression of Pro-/Anti-Inflammatory Cytokines in Alzheimer Disease Patients

Vakilian A, Razavi-Nasab SM, Ravari A, Mirzaei T, Moghadam-Ahmadi A, Jalali N, Bahramabadi R, Rezayati M, Yazdanpanah-Ravari A, Bahmaniar F, Bagheri MR, Sheikh Fathollahi M, Asadikaram G, Kazemi Arababadi M.

Neuroimmunomodulation. 2017;24(6):310-319. doi: 10.1159/000486597. Epub 2018 Mar 20.

Beyond Acetylcholinesterase Inhibitors: Novel Cholinergic Treatments for Alzheimer's Disease

Kamkwalala AR, Newhouse PA.

Curr Alzheimer Res. 2017;14(4):377-392. doi: 10.2174/1567205013666160930112625.

[Memantine as add-on medication to acetylcholinesterase inhibitor therapy for Alzheimer dementia]

Haussmann R, Donix M.

Nervenarzt. 2017 Jan;88(1):40-45. doi: 10.1007/s00115-016-0237-3.

Repetitive transcranial magnetic stimulation improves cognitive function of Alzheimer's disease patients

Zhao J, Li Z, Cong Y, Zhang J, Tan M, Zhang H, Geng N, Li M, Yu W, Shan P.

Oncotarget. 2017 May 16;8(20):33864-33871. doi: 10.18632/oncotarget.13060.

Towards an understanding of amyloid-β oligomers: characterization, toxicity mechanisms, and inhibitors

Lee SJ, Nam E, Lee HJ, Savelieff MG, Lim MH.

Chem Soc Rev. 2017 Jan 23;46(2):310-323. doi: 10.1039/c6cs00731g.

Alzheimer's disease and other dementias: update on research

Schneider L.

Lancet Neurol. 2017 Jan;16(1):4-5. doi: 10.1016/S1474-4422(16)30356-8.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias